While much progress has been made in Botswana, particularly in the area of treatment, expansion of HIV counseling and testing services (HCT) and in improving the African Comprehensive HIV/AIDS Partnerships' (ACHAP) institutional capacity to deliver effectively on its strategic objectives, much still needs to be done as part of a comprehensive, sustainable and successful response to the AIDS pandemic in that country. It is becoming increasingly apparent that if we are to get ahead of this epidemic, the focus needs to be on prevention.

In addition, ACHAP recognizes the need to build greater capacity among local organizations, increasing the capacity of communities to utilize and provide HIV and AIDS services. Therefore, priorities for ACHAP going forward will include the scaling up of prevention efforts, incorporating tuberculosis into the program, improving the cost effectiveness of the Masa antiretroviral treatment program and efforts to strengthen the capacity of local organizations for a sustainable national response.

The content on this page was last modified on September 15, 2009.

Merck & Co., Inc., Whitehouse Station, NJ, USA, and Schering-Plough Corporation, Kenilworth, NJ, USA, are now one company. We have combined our global operations under the name Merck & Co., Inc. We are working to update our corporate responsibility Web site to reflect our new, combined, global organization.